1 Answers
Option 1 : Russia
The Correct Answer is Russia.
- The DCGI (Drugs Controller General of India), the central drug regulator, has authorised the Russian vaccine Sputnik V for emergency use.
- After Covishield and Covaxin, it is also the third vaccine to receive emergency use authorization from the FDA.
- Last year, the Gamaleya National Research Institute of Epidemiology and Microbiology in Russia established the vaccine.
- Dr Reddy's Lab is conducting SPUTNIK V clinical trials in India.
- Dr Reddy's Lab, a multinational Indian pharmaceutical company headquartered in Hyderabad, has also signed a deal with the Russian Direct Investment Fund, RDIF, for the supply of Russian vaccines in India.
- SPUTNIK V was recommended for emergency use authorization by the Indian drug regulator's Subject Expert Committee.
- In clinical trials in the world, the vaccine has shown promising results.
- The Sputnik V vaccine is said to be 91.6% safe, according to RDIF. In February of this year, Dr Reddy's applied for emergency use of Sputnik-V.
- Russia President: Vladimir Putin (as of March 2021)
- Russia Capital: Moscow
- Russia Currency: Russian Ruble
5 views
Answered